| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2007 | WO2007140181A2 Combination therapy comprising an adenosine uptake inhibitor and a non-selective adenosine receptor antagonist |
| 12/06/2007 | WO2007140174A2 Compounds and methods for modulating fxr |
| 12/06/2007 | WO2007140146A2 Antimicrobial composition of 3-iodo-2-propynylbutyl carbamate and 1,3-butylene glycol as solvent |
| 12/06/2007 | WO2007140109A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 12/06/2007 | WO2007140059A2 High molecular weight chelation structure |
| 12/06/2007 | WO2007140022A2 Fucoidan compositions and methods |
| 12/06/2007 | WO2007140002A2 Method for treating non-hodgkin's lymphoma |
| 12/06/2007 | WO2007139992A2 ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS |
| 12/06/2007 | WO2007139984A2 Duloxetine hcl polymorphs |
| 12/06/2007 | WO2007139968A2 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | WO2007139961A1 Methods of reducing cell death following hypoxia / reoxygenation |
| 12/06/2007 | WO2007139955A2 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | WO2007139948A2 Imidazoazepinone compounds |
| 12/06/2007 | WO2007139939A2 Methods and compositions using immunomodulatory compounds in combination therapy |
| 12/06/2007 | WO2007139923A1 Deuterated aminoglycidyl compounds |
| 12/06/2007 | WO2007139897A1 Compositions and methods for the inhibition of endothelial nitric oxide synthase activity |
| 12/06/2007 | WO2007139887A2 Methods for treating bone or joint inflammation |
| 12/06/2007 | WO2007139886A2 Duloxetine hydrochloride delayed release formulations |
| 12/06/2007 | WO2007139860A2 Heterobicylic metalloprotease inhibitors |
| 12/06/2007 | WO2007139856A2 Heterobicyclic metalloprotease inhibitors |
| 12/06/2007 | WO2007139833A2 Imidazoazephinone compounds |
| 12/06/2007 | WO2007139818A2 Pharmacological treatment of cognitive impairment |
| 12/06/2007 | WO2007139813A1 Imidazoazephinone compounds |
| 12/06/2007 | WO2007139795A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 12/06/2007 | WO2007139782A2 Coating composition containing a human pheromone component |
| 12/06/2007 | WO2007139778A2 Rhamnose substituents of sl0101 and therapeutic uses thereof |
| 12/06/2007 | WO2007139775A2 N-methanocarba derivatives to treat cardiac diseases |
| 12/06/2007 | WO2007139760A2 Resorbable polymer compositions for use in medicine, dentistry, and surgery |
| 12/06/2007 | WO2007139753A2 Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels |
| 12/06/2007 | WO2007139749A2 Asymmetric synthesis of rocaglamides via enantioselective photocycloaddition mediated by chiral bronsted acids |
| 12/06/2007 | WO2007139732A1 Pyrazolo [1, 5-a] pyrimidines as cdk inhibitors |
| 12/06/2007 | WO2007139729A1 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| 12/06/2007 | WO2007139645A2 Immobilized 1,2-benzisothiazolin-3-one |
| 12/06/2007 | WO2007139569A1 Novel lapachone compounds and methods of use thereof |
| 12/06/2007 | WO2007139556A1 Combination of chemotherapeutic compounds for treating cancer |
| 12/06/2007 | WO2007139499A1 Compounds for use as a medicament |
| 12/06/2007 | WO2007139497A1 Levoglucosenone derivatives for the treatment of disorders such as cancer, autoimmune diseases and heart diseases. |
| 12/06/2007 | WO2007139496A1 Quinoline derivatives acting as tyrosine kinase inhibitors |
| 12/06/2007 | WO2007139464A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer |
| 12/06/2007 | WO2007139413A2 Polymorphs of (r) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1,3- dihydroimidazole-thione hydrochloride |
| 12/06/2007 | WO2007139350A1 Agent for preventing and treating infectious disease by influenza virus comprising cathechin derivative compounds |
| 12/06/2007 | WO2007139346A1 Composition for induction or inhibition of stem cell differentiation |
| 12/06/2007 | WO2007139260A1 An anticancer drug comprising inhibitor of tmprss4 |
| 12/06/2007 | WO2007139240A1 7-(3,4-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007139211A1 Process for production of optically active piperidine compound |
| 12/06/2007 | WO2007139190A1 Immunostimulatory oligonucleotide and pharmaceutical application thereof |
| 12/06/2007 | WO2007139176A1 Phosphine transition metal complex, method for producing the same and antitumor agent |
| 12/06/2007 | WO2007139153A1 Function-improving agent for cerebral dysfunction caused by environmental chemical |
| 12/06/2007 | WO2007139150A1 ANTI-INFLUENZA VIRAL AGENT COMPRISING TNF-α INHIBITOR |
| 12/06/2007 | WO2007139120A1 AMYLOID-β CLEARANCE ENHANCER |
| 12/06/2007 | WO2007139081A1 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep |
| 12/06/2007 | WO2007139062A1 Therapeutic agent for obesity, and method for treatment and prevention of obesity |
| 12/06/2007 | WO2007139036A1 Compound for controlling endoplasmic reticulum stress, and pharmaceutical composition comprising the compound as active ingredient |
| 12/06/2007 | WO2007139024A1 Composition for improvement of lipid metabolism |
| 12/06/2007 | WO2007139002A1 Method for producing nitrogen-containing fused ring compound |
| 12/06/2007 | WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound |
| 12/06/2007 | WO2007138997A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138974A1 Novel heterocyclic compound or salt thereof and intermediate thereof |
| 12/06/2007 | WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor |
| 12/06/2007 | WO2007138933A1 Remedy for diabetes |
| 12/06/2007 | WO2007138905A1 Intestinal eosinophil-suppressing composition |
| 12/06/2007 | WO2007138810A1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 12/06/2007 | WO2007138781A1 Antiviral agent and antibacterial agent |
| 12/06/2007 | WO2007138748A1 Pharmaceutical agent for recovery from fatigue |
| 12/06/2007 | WO2007138705A1 Tumor suppressor |
| 12/06/2007 | WO2007138611A1 3-(heterocyclyl)-n-(arylsulfonyl)indole derivatives as functional 5-ht6 ligands |
| 12/06/2007 | WO2007138606A2 Multiple unit pharmaceutical formulation |
| 12/06/2007 | WO2007138531A2 Treatment of erectile dysfunction and libido enhancement |
| 12/06/2007 | WO2007138472A2 Triazolopyridazine derivatives |
| 12/06/2007 | WO2007138466A2 Pharmaceutical compositions comprising meloxicam and tramadol combination |
| 12/06/2007 | WO2007138462A2 Aqueous oral formulations of risperidone |
| 12/06/2007 | WO2007138400A2 Hydrophilized anode for a direct liquid fuel cell |
| 12/06/2007 | WO2007138362A1 Use of gpcr agonists to delay progression of diabetes |
| 12/06/2007 | WO2007138355A1 Pyrrolo[1,2-a]pyrazin-1(2h)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2h)-one derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 12/06/2007 | WO2007138352A1 Zofenopril calcium |
| 12/06/2007 | WO2007138343A1 N-phenylamidines as 5-ht2a receptor antagonists |
| 12/06/2007 | WO2007138334A2 Methods for identifying an agent that modulates type i or type ii pip kinase activity or expression |
| 12/06/2007 | WO2007138322A1 New use for cannabinoid |
| 12/06/2007 | WO2007138311A1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase |
| 12/06/2007 | WO2007138304A1 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors |
| 12/06/2007 | WO2007138301A2 Novel formulation |
| 12/06/2007 | WO2007138282A2 Bi-aryl or aryl-heteroaryl substituted indoles |
| 12/06/2007 | WO2007138277A1 2-carbocycloamino-4-imidaz0lylpyrimidines as agents for the inhbition of cell proliferation |
| 12/06/2007 | WO2007138268A1 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation |
| 12/06/2007 | WO2007138263A1 Prevention and/or treatment of neurodegenerative disorders |
| 12/06/2007 | WO2007138242A1 Biphenyl derivatives and their use in treating hepatitis c |
| 12/06/2007 | WO2007138239A1 Cucurbitacine analogs or an extract from trichosanthes for treating anemia |
| 12/06/2007 | WO2007138234A1 Use of azasetron for the treatment of rosacea, and pharmaceutical compositions |
| 12/06/2007 | WO2007138233A2 Use of zatosetron for the treatment of rosacea, and pharmaceutical compositions |
| 12/06/2007 | WO2007138232A2 Use of granisetron for the treatment of sub-types of rosacea, and pharmaceutical compositions containing same |
| 12/06/2007 | WO2007138231A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof |
| 12/06/2007 | WO2007138225A1 Composition for controlling snoring, in the form of a nasal spray |
| 12/06/2007 | WO2007138224A1 Nasal and buccal compositions for controlling snoring |
| 12/06/2007 | WO2007138147A1 Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 12/06/2007 | WO2007138116A2 Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown |
| 12/06/2007 | WO2007138114A1 Use of prodrugs for ocular intravireous administration |
| 12/06/2007 | WO2007138113A1 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | WO2007138112A2 Compounds that interact with ion channels, in particular with ion channels from the kv family |